SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following reports that the company is preparing a formal bid for eBay, a move aimed at transforming the retailer into a massive e-commerce player. The community is actively debating the logistics of how GameStop, with its current cash reserves, would finance an acquisition of a company significantly larger than itself, while bulls anticipate a potential short squeeze and accelerated growth.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a sharp rally driven by heavy short interest and speculative momentum as traders position themselves ahead of the company's upcoming earnings report. The community is actively discussing the potential for a short squeeze, citing high borrow fees and limited share availability while debating the long-term strategic value of the stock's recent partnership and acquisition activity.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as market participants debate the impact of the end of the de minimis tariff exemption on its cross-border revenue and overall profit margins. While some traders are analyzing potential downside risks and short-term volatility, others remain focused on the company's long-term reliance on AI-driven marketplace improvements and the collectibles market to sustain growth.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is currently trending as a high-conviction buyout candidate, with investors actively discussing potential interest from major players like Netflix, Amazon, or Sony following the company's recent strategic spin-off. The community is heavily focused on the studio's strong IP library and the blockbuster box office potential of the Michael Jackson biopic as key catalysts that could drive a premium acquisition.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy is actively rallying behind its SOL-based token, with community members coordinating to drive momentum and recreate the market cap surges seen in previous cycles. Discussions are heavily focused on potential price runs, community-led buy pressure, and calls for long-term holding to reach previous market cap milestones.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community doubles down on long-term conviction, fueled by developer updates regarding a pivot toward business-oriented AI utility and a continued push for organic growth. Supporters are actively rallying behind the project's longevity and educational initiatives, viewing recent price action as a prime opportunity for accumulation before potential future developments.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as investors digest the commercial launch of NEREUS for motion sickness while debating the company's prospects for a potential buyout by major pharmaceutical players like Eli Lilly or Novo Nordisk. The community remains focused on the firm's strategic focus on GLP-1 adjunct treatments and active pipeline developments, even as participants express frustration over persistent price volatility and the company's aggressive regulatory strategy.

Pershing Square, Inc. operates as an alternative asset management company. It operates through the following business segments: Operating Assets, MPC,and Strategic Developments. The Operating Assets segment consists of developed or acquired retail, office, and multifamily properties along with other real estate investments. The MPC segments offers the development and sale of land in large-scale, long-term community development projects. The Strategic Developments segment provides residential condominium and commercial property projects currently under development. The company was founded by William A. Ackman on December 17, 2003 and is headquartered in New York, NY.

Pershing Square Inc.

Pershing Square Inc

Pershing Square is attracting intense market interest following its successful IPO, with investors closely watching Bill Ackman's strategy to navigate management fees and future fund launches. The community is actively debating the valuation and relationship between the management firm and its related closed-end fund, while monitoring for potential volatility as the IPO buzz settles.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a pivotal Phase 3 registration path for CAD-1005 in Heparin-Induced Thrombocytopenia, which followed a successful end-of-Phase 2 meeting with the FDA. While some investors are optimistic about the company's clinical progress and pipeline potential, a significant portion of the community is expressing frustration over frequent spam, bot activity, and concerns regarding the company's long-term financial stability and funding requirements.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

The DRC-20 token DOGI is gaining traction as investors highlight its integration with Doginals and the Doggy Market ecosystem alongside anticipation for upcoming utility developments. Community discussions are heavily focused on its role as a Dogecoin-based alternative to BRC-20 assets, with sentiment split between high-conviction accumulation and caution regarding broader meme coin volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 581,329 shares, a growth of 16.8% from the March 31st total of 497,753 shares. Based on an average...

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Consensus Rating of "Reduce" by Brokerages

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) has earned an average rating of "Reduce" from the four ratings firms that are currently covering the company, MarketBeat.com reports. Two...

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Large Growth in Short Interest

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) was the target of a large growth in short interest in March. As of March 13th, there was short interest totaling 478,579 shares, a growth...

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of "Hold" by Analysts

Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation an...

VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Verrica Pharmaceuticals Inc. (Verrica or the Company) (NASDAQ...

VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. VRCA

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA...

Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. VRCA

Verrica Pharmaceuticals Q4 Earnings Call Highlights

Verrica Pharmaceuticals (NASDAQ:VRCA) used its fourth quarter and year-end 2025 corporate update call to highlight what management described as a fundamental business transformation driven by sharper...

Verrica Pharmaceuticals (NASDAQ:VRCA) Announces Quarterly Earnings Results

Verrica Pharmaceuticals (NASDAQ:VRCA - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the...

Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded by Zacks Research to Hold

Zacks Research lowered shares of Verrica Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a report on Monday...

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Current Price	$6.27
Prev Close	$6.37
Open	$6.39
Dividend Yield	0.00%
50-Day Moving Average	$5.74
Beta	0.56
Avg. Volume	139,885.97
PE Ratio	-3.96

52-Week High	$9.82
52-Week Low	$3.28
Market Capitalization	$109.43M
EPS (Annual)	-$1.68
Price to Book	4.42
Revenue Per Employee	$468,118.42

VRCA
Verrica Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRCA News

VRCAVerrica Pharmaceuticals Inc